- Home
- SIGA vs CHW Comparison
SIGA vs CHW Comparison
Compare SIGA & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIGA | CHW |
|---|---|---|
| Founded | 1995 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.8M | 465.6M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SIGA | CHW |
|---|---|---|
| Price | $6.36 | $7.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 374.9K | 195.2K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | ★ 9.29% | 9.27% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $172,249,641.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $132.36 | N/A |
| P/E Ratio | $6.27 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.95 | $5.07 |
| 52 Week High | $9.62 | $6.54 |
Technical Indicators
Market Signals| Indicator | SIGA | CHW |
|---|---|---|
| Relative Strength Index (RSI) | 45.74 | 41.42 |
| Support Level | $6.13 | $7.32 |
| Resistance Level | $6.55 | $7.44 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 74.31 | 36.67 |
Price Performance
Historical ComparisonAbout SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.